JUP

Across TCGA pan-cancer cohorts, JUP Mutation is linked to patient survival in 5 of 34 cancer types, making it a survival-associated JUP data layer compared with 23 for mass-spec protein and 6 for mass-spec protein.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher JUP Mutation is associated with better overall survival. In most high-consensus cancer types, elevated JUP expression acts as an unfavorable survival marker, although some lineages such as UCEC show a favorable association.

UCEC, SCLC, and SKCM are the cancer types where JUP Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	OS	Median	All	0.976	0.864	.029	14	view →
SCLC	OS	Median	All	0.082	0.822	<.001	12	view →
SKCM	OS	Median	III,IV	0.271	0.729	.001	9	view →
PRAD	DFS	Median	All	0.617	0.886	.035	6	view →
ESCA	OS	Median	II,III,IV	0.216	0.702	.014	6	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

JUP–UCEC (OS)

Open the UCEC breakdown →